InsideTrading SEC Form 4 insider trades

Stocks

CUE Cue Biopharma, Inc.

Healthcare · Pharmaceutical Preparations · Market cap: $117.1M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $3.5M, sold $0 2022-Q2: bought $816.7K, sold $0 2022-Q3: bought $0, sold $0 2022-Q4: bought $0, sold $0 2023-Q1: bought $0, sold $30.6K 2023-Q2: bought $0, sold $0 2023-Q3: bought $19.6K, sold $0 2023-Q4: bought $0, sold $0 2024-Q1: bought $0, sold $0 2024-Q2: bought $0, sold $0 2024-Q3: bought $0, sold $0 2024-Q4: bought $30.9K, sold $0 2025-Q1: bought $0, sold $0 2025-Q2: bought $0, sold $0 2025-Q3: bought $0, sold $0 2025-Q4: bought $99.7K, sold $0 2026-Q1: bought $0, sold $0 2026-Q2: bought $0, sold $0 2026-Q3: bought $0, sold $2.0M 2026-Q4: bought $0, sold $389.3K
Bought, above the line (largest quarter $3.5M) Sold, below the line (largest quarter $2.0M)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$3.5M$0
2022-Q2$816.7K$0
2022-Q3$0$0
2022-Q4$0$0
2023-Q1$0$30.6K
2023-Q2$0$0
2023-Q3$19.6K$0
2023-Q4$0$0
2024-Q1$0$0
2024-Q2$0$0
2024-Q3$0$0
2024-Q4$30.9K$0
2025-Q1$0$0
2025-Q2$0$0
2025-Q3$0$0
2025-Q4$99.7K$0
2026-Q1$0$0
2026-Q2$0$0
2026-Q3$0$2.0M
2026-Q4$0$389.3K

Insider activity

Download CSV Up to 5,000 rows
Bought$4.5M8 buy days
Sold$3.0M11 sell days
Net insider flow+$1.5Mnet buying · 5 years
Latest trade2026-10-12Lin Shao-Lee
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-10-12 Sell Lin Shao-Lee CEO 11,087 $27.55 $305.5K 2
2026-10-12 Sell Ray Sumita Other C-suite 1,844 $28.05 $51.7K 1
2026-10-12 Sell Meluzio Michael Vincent VP 1,144 $28.05 $32.1K 1
2026-08-13 Sell Lin Shao-Lee CEO 18,258 $28.62 $522.6K 3
2026-08-13 Sell Ray Sumita Other C-suite 8,829 $30.09 $265.6K 3
2026-08-13 Sell Meluzio Michael Vincent VP 5,628 $30.09 $169.3K 3
2026-08-12 Sell Lin Shao-Lee CEO 40,000 $27.10 $1.1M 2
2025-12-30 Buy Sarraf Pasha Director 323,857 $0.31 $99.7K 5
2024-12-16 Buy PASSERI DANIEL R CEO 30,000 $1.03 $30.9K 1
2023-08-25 Buy Suri Anish President 4,000 $2.76 $11.0K 1
2023-08-14 Buy PASSERI DANIEL R CEO 3,000 $2.86 $8.6K 1
2023-03-23 Sell Kiener Peter A Director 9,325 $3.28 $30.6K 1
2022-05-27 Buy Morich Frank Director 28,000 $3.75 $105.0K 1
2022-05-24 Buy Fletcher Aaron G.L. Director 55,000 $3.34 $183.7K 1
2022-05-23 Buy Fletcher Aaron G.L. Director 150,000 $3.52 $528.0K 1
2022-03-31 Buy Fletcher Aaron G.L. Director 735,000 $4.76 $3.5M 1
2021-11-16 Sell Kiener Peter A Director 1,361 $18.02 $24.5K 1
2021-11-15 Sell Kiener Peter A Director 18,815 $17.92 $337.2K 1
2021-11-15 Sell Suri Anish President 8,000 $18.05 $144.4K 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
Fletcher Aaron G.L. Director $4.2M $0 2022-05-24
Lin Shao-Lee CEO $0 $1.9M 2026-10-12
Kiener Peter A Director $0 $392.3K 2023-03-23
Ray Sumita Other C-suite $0 $317.4K 2026-10-12
Meluzio Michael Vincent VP $0 $201.4K 2026-10-12
Suri Anish President $11.0K $144.4K 2023-08-25
Morich Frank Director $105.0K $0 2022-05-27
Sarraf Pasha Director $99.7K $0 2025-12-30
PASSERI DANIEL R CEO $39.5K $0 2024-12-16

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2018-12-11 → 2018-12-31 3 $747.4K 49 +0.9% (+13.1% raw)+59.9% (+77.7% raw)+86.6% (+106.7% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.